Invizyne Technologies Inc. (IZTC)

Invizyne Technologies will go public soon, but the exact IPO date is still unknown.
IPO Price
$8.00
Shares Offered
1,875,000
Deal Size
$15.00M
Chart not available yet
Data will show when the stock starts trading.
Market Cap 65.02M
Revenue (ttm) n/a
Net Income (ttm) -1.33M
Shares Out 8.13M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About IZTC

Invizyne is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought after chemicals. Our objective with SimplePath™, our biomanufacturing platform, is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. We believe that SimplePath™ not only can maximize the value of these resources but also will contribute to the development of novel chemical compo... [Read more]

Sector Materials
Founded 2019
Employees 29
Stock Exchange NASDAQ
Ticker Symbol IZTC
Full Company Profile

Financial Performance

Financial Statements

News

Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq

Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a...

9 months ago - GLOBE NEWSWIRE

Invizyne Technologies IPO Registration Document (S-1)

Invizyne Technologies has filed to go public with an IPO on the NASDAQ.

9 months ago - SEC

Biomanufacturing company Invizyne Technologies files and sets terms for a $17 million IPO

Invizyne Technologies, which is developing a biomanufacturing platform for a diverse range of chemicals, filed on Friday with the SEC to raise up to $17 million in an initial public offering.

9 months ago - Renaissance Capital